Skip to main content
SpringerLink
Log in

Follow-up of Patients with Resistant Hypertension

  • Chapter
  • First Online:
Resistant Hypertension

  • 1534 Accesses

Abstract

Resistant hypertension (RH) is defined as failure to reach goal blood pressure (BP) in spite of concurrent treatment with maximum tolerated doses of three antihypertensive agents of different classes, including a diuretic. Several trials have demonstrated that achievement of BP goals is still poor despite the use of several protocol-defined treatment regimens. Follow-up of these patients seems to be even more difficult since there are practically no data regarding long-term surveillance of patients with RH. This article provides an overview on the assessment and follow-up of patients with resistant hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Calhoun DA, Jones D, Textor S et al (2008) Resistant hypertension: diagnosis, evaluation, and treatment, a scientific statement from the American heart association professional education committee of the council for high blood pressure research. Hypertension 51:1403–1419

    Article  PubMed  CAS  Google Scholar 

  2. Epstein M (2007) Resistant hypertension: prevalence and evolving concepts. J Clin Hypertens (Greenwich) 9:2–6

    Google Scholar 

  3. ALLHAT officers and coordinators for the ALLHAT collaborative research group (2002) The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: the anti-hypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 288:2981–2997

    Google Scholar 

  4. Dahlof B, Devereux RB, Kjeldsen SE et al (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:995–1003

    Article  PubMed  CAS  Google Scholar 

  5. Pepine CJ, Handberg EM, Cooper-DeHoff RM et al (2003) A calcium antagonist versus a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 290:2805–2816

    Article  PubMed  CAS  Google Scholar 

  6. Lewington S, Clarke R, Qizilbash N et al (2002) Age-specific prevalence of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913

    Article  PubMed  Google Scholar 

  7. Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206–1252

    Article  PubMed  CAS  Google Scholar 

  8. Pickering TG, Hall JE, Appel LJ et al (2005) Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American heart association council on high blood pressure research. Circulation 111:697–716

    Article  PubMed  Google Scholar 

  9. Mancia G, De Backer G, Dominiczak A et al (2007) Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Eur Heart J 28(12):1462–1536

    PubMed  Google Scholar 

  10. Cheng TO (1998) Osler maneuver to detect pseudo hypertension. JAMA 282:943

    Article  Google Scholar 

  11. Redon J, Campos C, Narciso ML et al (1998) Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 31:712–718

    Article  PubMed  CAS  Google Scholar 

  12. Brown MA, Buddle ML, Martin A (2001) Is resistant hypertension really resistant? Am J Hypertens 14:1263–1269

    Article  PubMed  CAS  Google Scholar 

  13. Pierdomenico SD, Lapenna D, Bucci A et al (2005) Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant and true resistant hypertension. Am J Hypertens 18:1422–1428

    Article  PubMed  Google Scholar 

  14. Mazzaglia G, Mantovani LG, Sturkenboom MC et al (2005) Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 23:2093–2100

    Article  PubMed  CAS  Google Scholar 

  15. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD (1999) Persistence with treatment for hypertension in actual practice. CMAJ 160:31–37

    PubMed  CAS  Google Scholar 

  16. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A (2005) Rate and determinants of 10 year persistence with antihypertensive drugs. J Hypertens 23:2101–2107

    Article  PubMed  Google Scholar 

  17. Takiya LN, Peterson AM, Finley RS (2004) Meta-analysis of interventions for medication adherence to antihypertensives. Ann Pharmacother 38:1617–1624

    Article  PubMed  Google Scholar 

  18. Hall JE (2003) The kidney, hypertension, and obesity. Hypertension 41:625–633

    Article  PubMed  Google Scholar 

  19. Sarafidis PA (2008) Obesity, insulin resistance and kidney disease risk: insights into the relationship. Curr Opin Nephrol Hypertens 17:450–456

    Article  PubMed  CAS  Google Scholar 

  20. Morris MJ (2008) Cardiovascular and metabolic effects of obesity. Clin Exp Pharmacol Physiol 35:416–419

    Article  PubMed  CAS  Google Scholar 

  21. Wong C, Marwick TH (2007) Obesity cardiomyopathy: pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med 4:436–443

    Article  PubMed  CAS  Google Scholar 

  22. Mertens LI, Van Gaal LF (2000) Overweight, obesity, and blood pressure: the effects of modest weight reduction, 8(3):270–278

    Google Scholar 

  23. Aucott L, Poobalan A, Smith WC et al (2005) Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review. Hypertension 45:1035–1041

    Article  PubMed  CAS  Google Scholar 

  24. Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206–1252

    Article  PubMed  CAS  Google Scholar 

  25. Wildman RP, Gu D, Muntner P et al (2005) Alcohol intake and hypertension subtypes in Chinese men. J Hypertens 23:737–743

    Article  PubMed  CAS  Google Scholar 

  26. Aguilera MT, de la Sierra A, Coca A et al (1999) Effect of alcohol abstinence on blood pressure: assessment by 24 h ambulatory blood pressure monitoring. Hypertension 33:653–657

    Article  PubMed  CAS  Google Scholar 

  27. Nishizaka MK, Pratt-Ubunama M, Zaman MA et al (2005) Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. Am J Hypertens 18:805–812

    Article  PubMed  CAS  Google Scholar 

  28. He FJ, MacGregor GA (2004) Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 3:CD004937

    Google Scholar 

  29. Boudville N, Ward S, Benaroia M, House AA (2005) Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease. Am J Hypertens 18:1300–1305

    Article  PubMed  CAS  Google Scholar 

  30. Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206–1252

    Article  PubMed  CAS  Google Scholar 

  31. Forman JP, Stampfer MJ, Curhan GC (2005) Non-narcotic analgesic dose and risk of incident hypertension in US women. Hypertension 46:500–507

    Article  PubMed  CAS  Google Scholar 

  32. Johnson AG, Nguyen TV, Day RO (1994) Do nonsteroidal anti-inflammatory drugs affect blood pressure? a meta-analysis. Ann Intern Med 121:289–300

    Article  PubMed  CAS  Google Scholar 

  33. Radack KL, Deck CC, Bloomfield SS (1987) Ibuprofen interferes with the efficacy of antihypertensive drugs, a randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med 107:628–635

    Article  PubMed  CAS  Google Scholar 

  34. Conlin PR, Moore TJ, Swartz SL et al (2000) Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients. Hypertension 36:461–465

    Article  PubMed  CAS  Google Scholar 

  35. Wessel TR, Arant CB, Olson MB et al (2004) Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA 292:1179–1187

    Article  PubMed  CAS  Google Scholar 

  36. Aucott L, Poobalan A, Smith WC et al (2005) Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review. Hypertension 45:1035–1041

    Article  PubMed  CAS  Google Scholar 

  37. Kokkinos PF, Narayan P, Colleran JA et al (1995) Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med 333:1462–1467

    Article  PubMed  CAS  Google Scholar 

  38. Ohira T, Tanigawa T, Tabata M et al (2009) Effects of habitual alcohol intake on ambulatory blood pressure, heart rate, and its variability among Japanese men. Hypertension 53:13–19

    Article  PubMed  CAS  Google Scholar 

  39. Chobanian AV, Bakris GL, Black HR et al (2003) National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee, the seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2572

    Article  PubMed  CAS  Google Scholar 

  40. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM (2003) Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 42:878–884

    Article  PubMed  CAS  Google Scholar 

  41. He FJ, Markandu ND, MacGregor GA (2005) Modest salt reduction lowers blood pressure in isolated systolic hypertension and combined hypertension. Hypertension 46:66–70

    Article  PubMed  CAS  Google Scholar 

  42. Wong DN, Lopez VA, L’Italien G, Chen R, Kline SE, Franklin SS (2007) Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003–2004. Arch Intern Med 167(22):2431–2436

    Article  PubMed  Google Scholar 

  43. Persell SD (2011) Prevalence of resistant hypertension in the United States, 2003–2008. Hypertens Jun 57(6):1076–1080

    Google Scholar 

  44. De la Sierra A, Segura J, Banegas JR, et al (2011) Clinical features of 8,295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 57:898e902

    Google Scholar 

  45. Kallistratos MS, Giannakopoulos A, German V, Manolis AJ (2010) Diagnostic modalities of most common forms of secondary hypertension. Hellenic J Cardiol 51:518–529

    PubMed  Google Scholar 

  46. Cushman WC, Ford CE, Cutler JA et al (2002) Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 4:393–404

    Article  Google Scholar 

  47. Campese VM, Mitra N, Sandee D (2006) Hypertension in renal parenchymal disease: why is it so resistant to treatment? Kidney Int 69:967–973

    Article  PubMed  CAS  Google Scholar 

  48. Greco BA, Breyer JA (1997) Atherosclerotic ischemic renal disease. Am J Kid Dis 29:167–187

    Article  PubMed  CAS  Google Scholar 

  49. Uzu T, Inoue T, Fujii T et al (1997) Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis 29:733–738

    Article  PubMed  CAS  Google Scholar 

  50. Wilms G, Marchal G, Peene P, Baert AL (1990) The angiographic incidence of renal artery stenosis in the arteriosclerotic population. Eur J Radiol 10:195–197

    Article  PubMed  CAS  Google Scholar 

  51. Hansen KJ, Edwards MS, Craven TE et al (2002) Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 36:443–451

    Article  PubMed  Google Scholar 

  52. Rossi GP, Bernini G, Caliumi C et al (2006) PAPY Study investigators, a prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293–2300

    Article  PubMed  CAS  Google Scholar 

  53. Leung AM, Sasano H, Nishikwa T et al (2008) Multiple unilateral adrenal adenomas in a patient with primary hyperaldosteronism. Endocr Pract 14:76–79

    Article  PubMed  Google Scholar 

  54. Pimenta E, Calhoun DA (2007) Resistant hypertension and aldosteronism. Curr Hypertens Rep 9:353–359

    Article  PubMed  CAS  Google Scholar 

  55. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1384

    Article  PubMed  CAS  Google Scholar 

  56. Logan AG, Perlikowski SM, Mente A (2001) High prevalence of obstructive sleep apnea in drug resistant hypertension. J Hypertension 19:2271–2277

    Article  CAS  Google Scholar 

  57. Narkiewicz K, van de Borne PJH, Pesek CA, Dyken ME, Montano N, Somers VK (1999) Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99:1183–1189

    Article  PubMed  CAS  Google Scholar 

  58. Mulgrew AT, Fox N, Ayas NT, Ryan CF (2007) Diagnosis and initial management of obstructive sleep apnea without polysomnography. Ann Intern Med 146:157–166

    Article  PubMed  Google Scholar 

  59. Skomro RP, Gjevre J, Reid J et al (2010) Outcomes of home-based diagnosis and treatment of obstructive sleep apnea. Chest 138(2):257–263

    Article  PubMed  Google Scholar 

  60. Logan AG, Tkacova R, Perlikowski SM et al (2003) Refractory hypertension and sleep apnea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 21:241–247

    Article  PubMed  CAS  Google Scholar 

  61. Textor SC (2002) Progressive hypertension in a patient with “incidental” renal artery stenosis. Hypertension 40:595–600

    Article  PubMed  CAS  Google Scholar 

  62. O’Donovan RM, Gutierrez OH, Izzo JL Jr (1992) Preservation of renal function by percutaneous renal angioplasty in high-risk elderly patients: short-term outcome. Nephron 60:187–192

    Article  PubMed  Google Scholar 

  63. Suresh M, Laboi P, Mamtora H, Kalra PA (2000) Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol Dial Transplant 15:631–636

    Article  PubMed  CAS  Google Scholar 

  64. Gupta AK, Arshad S, Poulter NR (2010) Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 55:399–407

    Article  PubMed  CAS  Google Scholar 

  65. Radack KL, Deck CC, Bloomfield SS (1987) Ibuprofen interferes with the efficacy of antihypertensive drugs, a randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med 107:628–635

    Article  PubMed  CAS  Google Scholar 

  66. Calvo C, Hermida RC, Ayala DE et al (2006) Effects of time-dependent administration of antihypertensive treatment in patients with resistant hypertension. Med Clin (Barc) 126:364–372

    Article  Google Scholar 

  67. Hermida RC, Ayala DE, Fernández JR, Calvo C (2008) Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 51:69–76

    Article  PubMed  CAS  Google Scholar 

  68. Graves JW, Bloomfield RL, Buckalew VM Jr (1989) Plasma volume in resistant hypertension: guide to pathophysiology and therapy. Am J Med Sci 298:361–365

    Article  PubMed  CAS  Google Scholar 

  69. Khosla N, Chua DY, Elliott WJ et al (2005) Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications? J Clin Hypertens 7:354–356

    Article  Google Scholar 

  70. Ernst ME, Goerdt CJ, Carter BL et al (2006) Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47:352–358

    Article  PubMed  CAS  Google Scholar 

  71. Khosla N, Chua DY, Elliott WJ, Bakris GL (2005) Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications? J Clin Hypertens (Greenwich) 7:354–356

    Article  Google Scholar 

  72. Nishizaka MK, Calhoun DA (2005) The role of aldosterone antagonists in the management of resistant hypertension. Curr Hypertens Rep 7:343–347

    Article  PubMed  CAS  Google Scholar 

  73. Nishizaka MK, Zaman MA, Calhoun DA (2003) Efficacy of low-dose Spironolactone in subjects with resistant hypertension. Am J Hypertens 16:925–930

    Article  PubMed  CAS  Google Scholar 

  74. Chapman N, Dobson J, Wilson S et al (2007) Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 49:839–845

    Google Scholar 

  75. Krum H, Nolly H, Workman D et al (2007) Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients. Hypertension 2002(40):117–123

    Google Scholar 

  76. Eide IK, Torjesen PA, Drolsum A, Babovic A, Lilledahl NP (2004) Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. J Hypertens 22:2217–2226

    Article  PubMed  CAS  Google Scholar 

  77. Saseen JJ, Carter BL, Brown TE et al (1996) Comparison of nifedipine alone and with diltiazem or verapamil in hypertension. Hypertension 28:109–114

    Article  PubMed  CAS  Google Scholar 

  78. Gashti CN, Bakris GL (2004) The role of calcium antagonists in chronic kidney disease. Curr Opin Nephrol Hypertens 13:155–161

    Article  PubMed  CAS  Google Scholar 

  79. Stergiou GS, Makris T, Papavasiliou M et al (2005) Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy. J Hypertens 23:883–889

    Article  PubMed  CAS  Google Scholar 

  80. Yusuf S, Teo KK, Pogue J et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358:1547–1559

    Article  PubMed  CAS  Google Scholar 

  81. Mann JF, Schmieder R, McQueen M et al (2008) Renal outcomes with telmisartan, ramipril, or both in people at high vascular risk: results from a multicenter, randomised, double-blind, controlled trial. Lancet 372:547–553

    Article  PubMed  CAS  Google Scholar 

  82. Black HR, Bakris GL, Weber MA et al (2007) Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study. J Clin Hypertens (Greenwich) 9:760–769

    Article  CAS  Google Scholar 

  83. Kostis JB, Packer M, Black HR et al (2004) Omapatrilat and enalapril in patients with hypertension: the Omapatrilat cardiovascular treatment vs, Enalapril (OCTAVE) trial. Am J Hypertens 17:103–111

    Article  PubMed  CAS  Google Scholar 

  84. Brown MJ, Coltart J, Gunewardena K et al (2004) Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects. Clin Sci (Lond) 107:167–173

    Article  CAS  Google Scholar 

  85. Ambühl PM, Tissot AC, Fulurija A et al (2007) A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. J Hypertens 25:63–72

    Article  PubMed  Google Scholar 

  86. Heusser Karsten, Tank Jens, Engeli Stefan (2010) Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 55:619–626

    Article  PubMed  CAS  Google Scholar 

  87. Scheffers IJ, Kroon AA, Schmidli J et al (2010) Novel baroreflex activation therapy in resistant hypertension results of a European multi-center feasibility study. JACC 56(15):1254–1258

    Article  PubMed  Google Scholar 

  88. Campese VM, Kogosov E (1995) Renal afferent denervation prevents hypertension in rats with chronic renal failure part 2, Hypertension 25(4):878–882

    Google Scholar 

  89. Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275–1281

    Article  PubMed  Google Scholar 

  90. Symplicity HTN-2 Investigators (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376(9756):1903–9

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology Department of Asklepeion General Hospital, Vasileos Pavlou 1 Voula, 16673, Athens, Greece

    Manolis S. Kallistratos & Athanasios J. Manolis

  2. Cardiology Department, St Thomas’ Hospital, Westminster Bridge Road, London, SE1 7EH, UK

    Antonios N. Pavlidis

Authors
  1. Manolis S. Kallistratos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonios N. Pavlidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Athanasios J. Manolis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Athanasios J. Manolis .

Editor information

Editors and Affiliations

  1. IRCCS Istituto Auxologico Italiano, University of Milano Bicocca, Milan, Italy

    Giuseppe Mancia

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Italia

About this chapter

Cite this chapter

Kallistratos, M.S., Pavlidis, A.N., Manolis, A.J. (2013). Follow-up of Patients with Resistant Hypertension. In: Mancia, G. (eds) Resistant Hypertension. Springer, Milano. https://doi.org/10.1007/978-88-470-5415-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5415-8_14

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5414-1

  • Online ISBN: 978-88-470-5415-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation